1 / 9

Joint assessment of modifiers and/confounders

Joint assessment of modifiers and/confounders. Maybe one-at-time assessment is not enough The merits of regression analysis start to kick in!. Joint effect modification. Now consider a model like: (Yikes!) …but this is just 4 lines: E(Y) versus age; For the 4 groups:

edan-suarez
Download Presentation

Joint assessment of modifiers and/confounders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Joint assessment of modifiers and/confounders Maybe one-at-time assessment is not enough The merits of regression analysis start to kick in!

  2. Joint effect modification • Now consider a model like: • (Yikes!) • …but this is just 4 lines: E(Y) versus age; • For the 4 groups: • Females receiving placebo: • Males receiving placebo: • Females receiving active:

  3. …and lastly • Males receiving active: • How do we interpret this ..er mess? • Look at the drug effect for each gender as a function of age

  4. Drug effect is: active - placebo • For females: • For males: • How does drug effect depend on gender? • Take the difference again: • So we can see that measures the extent to which gender as an effect modifier depends on age

  5. But also measures: • The extent to which age as an effect modifier depends on gender • You can spin the interpretation in either way here (as is the case with most ‘interaction’ measures)

  6. Now lets look at the ‘3 factor’ example from Rabe-Hesketh • Define indicator variables for each of the 3 drug groups: x, y and z • Decide on a ‘baseline’ drug group: say x. • The model’s estimates/predcitions do not depend on this choice but do provide interpretations for the coefficients • Since there are 3 groups, we need 2 coefficients to display the 2 degrees of freedom associated with the differences among the 3 groups

  7. Then we can build a ‘saturated’ model • This model will give estimates that reproduce the 12 cell averages • The model separates into a number of 2 df sets:

  8. Notice that this last set of 2 df: • Can be expressed in 3 ways (each way means the same thing!): • How does the diet/biofeed interaction depend on drug group? • How does the drug/diet interaction depend on biofeed group? • How does the drug/biofeed interaction depend on diet group?

  9. The decision to whether to (and how to) separate up the 2 df sets should be made ‘in advance’ • Individual one df tests can be made using the usual t-tests. It is always to good idea to check out ‘what such tests mean’ (what a concept!) • Of course, it may be that 2(or more) df tests cover the issues at hand. In such cases, one should offer the appropriate F test. • For example, if one fits: • regr sbp x y d b db dx dy bx by dbx dby • …and then tries: • test dbx=dby=0 • One receives the 2 df F test for ‘whether or not the db interaction depends on drug group’

More Related